Senzime AB

Equities

SEZI

SE0002478776

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm Other stock markets 11:29:50 2024-05-17 am EDT			5-day change	1st Jan Change
6.68 ^SEK	-2.62%		-4.43%	-10.09%

May. 07	Transcript : Senzime AB, Q1 2024 Earnings Call, May 07, 2024
May. 07	Senzime AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Senzime AB Announces the Demises of Ulf Lindskog, Member of Board of Directors

June 07, 2019 at 04:45 am EDT

Senzime AB (publ) announced that Ulf Lindskog passed away on June 5 after a period of illness at the age of 75. Ulf was elected member of Senzime's Board of Directors in 2010 and has been a highly appreciated member of Senzime's board.

Latest news about Senzime AB

Transcript : Senzime AB, Q1 2024 Earnings Call, May 07, 2024	May. 07
Senzime AB Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 07	CI
Senzime Signs First Group Purchasing Organization Contract with Major US Hospital System as Sole Source Supplier	Apr. 26	CI
Senzime Announces Major Public Tender Contract by the US Department of Veterans Affairs	Apr. 24	CI
Senzime AB Secures Multiple Top-Rated US Hospital Deals	Apr. 10	CI
Transcript : Senzime AB - Special Call	Mar. 20
Senzime Wins its Largest US Deal to Date from Leading Houston Based University Hospital System	Mar. 07	CI
Transcript : Senzime AB, Q4 2023 Earnings Call, Feb 15, 2024	Feb. 15
Senzime AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 15	CI
Senzime Licensee Fukuda Denshi Launches Integrated Tetragraph Module in Japanese Market	Feb. 07	CI
Senzime Bolsters US Operations with Team Expansion, Office Relocation	Jan. 17	MT
Senzime Relocates its US headquarters from Boston to St. Louis, MO	Jan. 17	CI
Senzime AB Secures Initial TetraGraph Order from Major New York Metropolitan Region University Hospital Group	Dec. 21	CI
Senzime AB Secures Multiple University Hospital Orders in Germany	Nov. 30	CI
Senzime AB Announces Board Changes	Nov. 28	CI
Senzime Announces New Clinical Study with the Tetragraph System Published in the British Journal of Anesthesia Open	Nov. 08	CI
Senzime Debuts on OTCQX Market; Stocks Rise	23-10-27	MT
Transcript : Senzime AB, Q3 2023 Earnings Call, Oct 26, 2023	23-10-26
Senzime AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-26	CI
Senzime Wins Supply Contract for TetraGraph Monitoring System in US	23-10-13	MT
Senzime Secures Contract with University Hospital System	23-10-13	CI
Senzime Launches Tetras Sensitive, the Market's First Sensor for Nemomuscular Monitoring of Patients with Sensitive Skin	23-10-09	CI
Senzime Wins TetraGraph Order in US; Stock Surges	23-09-18	MT
Senzime Secures Additional Major US Hospital Contract	23-09-18	CI
Sweden's Senzime Seeks Listing on OTCQX Trading Platform in US	23-09-12	MT

Chart Senzime AB

Duration

Period

More charts

Company Profile

Senzime publ AB is a Sweden-based company engaged in the development, manufacture and marketing of biosensors for measuring metabolites in biological fluids, such as human blood and cell culture substrates for the pharmaceutical and healthcare segments. The Company focuses on the following application areas: medical diagnostic instruments, pharmaceutical industry, chemical processing, and food and beverage processing. As of December 31, 2011, the Company marketed three products, namely SENZ-100G, for continuous analysis of glucose in the fermentation solutions; SENZ-100L, for continuous analysis of lactate in fermentation solutions, and SENZ-200G, for continuous analysis of glucose in blood during intensive care.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-24 - Euroanaesthesia Conference

More about the company

Income Statement Evolution

More financial data

Ratings for Senzime AB

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
SENZIME AB	-10.09%	76.73M
ABBOTT LABORATORIES	-5.43%	182B
MEDTRONIC PLC	+4.30%	114B
BECTON, DICKINSON AND COMPANY	-3.09%	68.38B
DEXCOM, INC.	+5.86%	52.46B
CENCORA, INC.	+8.15%	44.25B
HOYA CORPORATION	+7.52%	43.55B
METTLER-TOLEDO INTERNATIONAL, INC.	+25.54%	32.69B
TERUMO CORPORATION	+17.85%	26.73B
WEST PHARMACEUTICAL SERVICES, INC.	+1.00%	25.79B

Other Medical Equipment, Supplies & Distribution